This research report focuses on the Gastrointestinal Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Oral
- 1.2.3 Parenteral
- 1.3 Market by Application
- 1.3.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 IBD
- 1.3.3 Irritable Bowel Syndrome (IBS)
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Gastrointestinal Therapeutics Market Perspective (2017-2028)
- 2.2 Gastrointestinal Therapeutics Growth Trends by Region
- 2.2.1 Gastrointestinal Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2017-2022)
- 2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028)
- 2.3 Gastrointestinal Therapeutics Market Dynamics
- 2.3.1 Gastrointestinal Therapeutics Industry Trends
- 2.3.2 Gastrointestinal Therapeutics Market Drivers
- 2.3.3 Gastrointestinal Therapeutics Market Challenges
- 2.3.4 Gastrointestinal Therapeutics Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Gastrointestinal Therapeutics Players by Revenue
- 3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2017-2022)
- 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2017-2022)
- 3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
- 3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
- 3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2021
- 3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served
- 3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
- 3.7 Date of Enter into Gastrointestinal Therapeutics Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics Breakdown Data by Type
- 4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2017-2022)
- 4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Therapeutics Breakdown Data by Application
- 5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2017-2022)
- 5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Gastrointestinal Therapeutics Market Size (2017-2028)
- 6.2 North America Gastrointestinal Therapeutics Market Size by Type
- 6.2.1 North America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
- 6.2.2 North America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
- 6.2.3 North America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
- 6.3 North America Gastrointestinal Therapeutics Market Size by Application
- 6.3.1 North America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
- 6.3.2 North America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
- 6.3.3 North America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
- 6.4 North America Gastrointestinal Therapeutics Market Size by Country
- 6.4.1 North America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
- 6.4.2 North America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Gastrointestinal Therapeutics Market Size (2017-2028)
- 7.2 Europe Gastrointestinal Therapeutics Market Size by Type
- 7.2.1 Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022)
- 7.2.2 Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028)
- 7.2.3 Europe Gastrointestinal Therapeutics Market Share by Type (2017-2028)
- 7.3 Europe Gastrointestinal Therapeutics Market Size by Application
- 7.3.1 Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022)
- 7.3.2 Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028)
- 7.3.3 Europe Gastrointestinal Therapeutics Market Share by Application (2017-2028)
- 7.4 Europe Gastrointestinal Therapeutics Market Size by Country
- 7.4.1 Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022)
- 7.4.2 Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2017-2028)
- 8.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type
- 8.2.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application
- 8.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
- 8.4.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Gastrointestinal Therapeutics Market Size (2017-2028)
- 9.2 Latin America Gastrointestinal Therapeutics Market Size by Type
- 9.2.1 Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
- 9.2.2 Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
- 9.2.3 Latin America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
- 9.3 Latin America Gastrointestinal Therapeutics Market Size by Application
- 9.3.1 Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
- 9.3.2 Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
- 9.3.3 Latin America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
- 9.4 Latin America Gastrointestinal Therapeutics Market Size by Country
- 9.4.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
- 9.4.2 Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2017-2028)
- 10.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type
- 10.2.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application
- 10.3.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
- 10.4.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Company Details
- 11.1.2 AbbVie Business Overview
- 11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
- 11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.1.5 AbbVie Recent Developments
- 11.2 Allergan
- 11.2.1 Allergan Company Details
- 11.2.2 Allergan Business Overview
- 11.2.3 Allergan Gastrointestinal Therapeutics Introduction
- 11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.2.5 Allergan Recent Developments
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Company Details
- 11.3.2 Johnson & Johnson Business Overview
- 11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
- 11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.3.5 Johnson & Johnson Recent Developments
- 11.4 Takeda
- 11.4.1 Takeda Company Details
- 11.4.2 Takeda Business Overview
- 11.4.3 Takeda Gastrointestinal Therapeutics Introduction
- 11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.4.5 Takeda Recent Developments
- 11.5 Novartis
- 11.5.1 Novartis Company Details
- 11.5.2 Novartis Business Overview
- 11.5.3 Novartis Gastrointestinal Therapeutics Introduction
- 11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.5.5 Novartis Recent Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Pfizer Business Overview
- 11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
- 11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.6.5 Pfizer Recent Developments
- 11.7 Merck
- 11.7.1 Merck Company Details
- 11.7.2 Merck Business Overview
- 11.7.3 Merck Gastrointestinal Therapeutics Introduction
- 11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.7.5 Merck Recent Developments
- 11.8 F. Hoffmann-La Roche
- 11.8.1 F. Hoffmann-La Roche Company Details
- 11.8.2 F. Hoffmann-La Roche Business Overview
- 11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
- 11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.8.5 F. Hoffmann-La Roche Recent Developments
- 11.9 Eli Lilly
- 11.9.1 Eli Lilly Company Details
- 11.9.2 Eli Lilly Business Overview
- 11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
- 11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.9.5 Eli Lilly Recent Developments
- 11.10 AstraZeneca
- 11.10.1 AstraZeneca Company Details
- 11.10.2 AstraZeneca Business Overview
- 11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
- 11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.10.5 AstraZeneca Recent Developments
- 11.11 Procter & Gamble
- 11.11.1 Procter & Gamble Company Details
- 11.11.2 Procter & Gamble Business Overview
- 11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
- 11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.11.5 Procter & Gamble Recent Developments
- 11.12 Tillotts Pharma
- 11.12.1 Tillotts Pharma Company Details
- 11.12.2 Tillotts Pharma Business Overview
- 11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
- 11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.12.5 Tillotts Pharma Recent Developments
- 11.13 Takeda
- 11.13.1 Takeda Company Details
- 11.13.2 Takeda Business Overview
- 11.13.3 Takeda Gastrointestinal Therapeutics Introduction
- 11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.13.5 Takeda Recent Developments
- 11.14 GlaxoSmithKline
- 11.14.1 GlaxoSmithKline Company Details
- 11.14.2 GlaxoSmithKline Business Overview
- 11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
- 11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.14.5 GlaxoSmithKline Recent Developments
- 11.15 Amgen
- 11.15.1 Amgen Company Details
- 11.15.2 Amgen Business Overview
- 11.15.3 Amgen Gastrointestinal Therapeutics Introduction
- 11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022)
- 11.15.5 Amgen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer